Fingerprint
Dive into the research topics of 'Nivolumab in combination with platinum-based doublet chemotherapy for first-line treatment of advanced non-small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Naiyer A. Rizvi, Matthew D. Hellmann, Julie R. Brahmer, Rosalyn A. Juergens, Hossein Borghaei, Scott Gettinger, Laura Q. Chow, David E. Gerber, Scott A. Laurie, Jonathan W. Goldman, Frances A. Shepherd, Allen C. Chen, Yun Shen, Faith E. Nathan, Christopher T. Harbison, Scott Antonia
Research output: Contribution to journal › Article › peer-review